Three Medical Device Companies Sue Brainlab and the University of Chicago

  • August 2, 2012

Image-Based Surgicenter (IBSC)NeuroGrafix [NPE], and Neurography Institute Medical Associates (NIMA) filed suit against Brainlab,  the University of Chicago, and the University of Chicago Medical Center, alleging that the defendants’ use of products for peripheral nerve MR Neurography, DTI, and diffusion anisotropy-based tractography, including related workstations and software, infringe a patent related to medical imaging.  NeuroGrafix has filed nine prior suits since May 2008 against defendants, including  Beth Israel Deaconess Medical Center and Children’s Hospital Medical Care CorporationBeth Israel Deaconess Physicians OrganizationBoston Medical Center CorporationBoston University Affiliated PhysiciansBoston University Medical Center RadiologistsBrigham and Women’s Hospital, Brigham and Women’s Physicians OrganizationCaregroupHarvard Medical Faculty Physicians at Beth Israel Deaconess Medical CenterJohn Hopkins Hospital, John Hopkins University, Oak Tree Medical Corporation, Partners Healthcare SystemPhilips, Siemens, University of California, President and Fellows of Harvard CollegeTrustees of Boston University, Trustees of Tufts CollegeTufts Medical Center Physicians Organization, and Tufts Shared Services. The plaintiffs have also been subject to one action for declaratory judgment brought by GE in May 2012.  The patent-in-suit was assigned to the University of Washington by St. George’s Hospital Medical School in February 2008.  According to the complaint, Washington Research Fund holds all rights to the patent-in-suit, which was exclusively licensed to NeuroGrafix in December 1998.  NeuroGrafix, NIMA, and IBSC have reportedly been investing in and practicing the technology in the patent-in-suit since at least 2000.  8/1, Northern District of Illinois, no judge yet assigned, 1:2012cv06068, 1:2012cv06075.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×